Clinical Trials

IU Health Bloomington understands that clinical research is an important contributor to patient satisfaction and improved clinical outcomes. The hospital is committed to aggressively developing a robust research environment in order to better serve the surrounding community and improve access to care throughout the IU Health System. 

Our commitment to developing and maintaining a collaborative research environment allows our physicians to explore a variety of treatment options and allows them to provide cutting-edge therapies to their patients. Below is a list of the clinical trials available for participation at IU Health Bloomington.  Please contact the IU Health Bloomington research office 812.353.5494 for more information.

Breast Cancer

SCUSF-0806    PI-David Lee, MD 

Phase II placebo-controlled trial of lisinopril and Coreg CR to reduce cardiotoxicity in patients with breast cancer receiving (neo) adjuvant chemotherapy with trastuzumab (Herceptin)

More information about this study

PROMIS  PI-Benjamin Parsons, DO

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score (PROMIS)

More information about this study

Prostate Cancer

CALBG 70807   PI-David Lee, MD 

The Men’s Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance.

More information about this study

RTOG 0815  PI-David Lee, MD 

A Phase III prospective randomized trial of dose-escalated radiotherapy with or without short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer.

More information about this study

Multiple Myeloma

HOG MM12  PI-Benjamin Parsons, DO

A Phase 1/2, Multicenter, Single-arm, Nonrandomized, Open-label and Dose-escalation Study of Weekly Carfilzomib and Dexamethasone for Patients With Progressive Multiple Myeloma.

More information about this study


DSC127-2012  PI-Jodie Harper, MD

A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Care-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects with Diabetes Mellitus

More information about this study


The Indiana Biobank

A collection of a blood sample and personal health information for use in future research studies